Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
Public ClinicalTrials.gov record NCT00919113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Parallel Group Evaluation of the Effectiveness and Safety of Uracyst® Compared to Inactive Control in Subjects With Interstitial Cystitis/Painful Bladder Syndrome
Study identification
- NCT ID
- NCT00919113
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Interventions
- 2% sodium chondroitin sulfate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2009
- Primary completion
- Nov 30, 2010
- Completion
- Nov 30, 2010
- Last update posted
- May 2, 2013
2009 – 2010
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Denver | Colorado | 80211 | — |
| Not listed | Farmington | Connecticut | 06032 | — |
| Not listed | Plantation | Florida | 33317 | — |
| Not listed | Wellington | Florida | 33414 | — |
| Not listed | Columbus | Georgia | 31904 | — |
| Not listed | Coeur d'Alene | Idaho | 83814 | — |
| Not listed | Evanston | Illinois | 60201 | — |
| Not listed | Melrose Park | Illinois | 60160 | — |
| Not listed | Royal Oak | Michigan | 48073 | — |
| Not listed | Las Vegas | Nevada | 89148 | — |
| Not listed | Englewood | New Jersey | 07601 | — |
| Not listed | Sewell | New Jersey | 08080 | — |
| Not listed | Woodlane | New Jersey | 08060 | — |
| Not listed | Albany | New York | 12206 | — |
| Not listed | Poughkeepsie | New York | 12601 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Mountlake Terrace | Washington | 98043 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00919113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2013 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00919113 live on ClinicalTrials.gov.